A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease

Project Information

NILVAD

Grant agreement ID: 279093

Project closed

Start date 1 January 2012

End date 30 June 2017

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 916 016,43

EU contribution € 5 999 978,00

Coordinated by

THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
Ireland